Upload
raven-thomas
View
84
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Inflammatory Response: Current Concepts. Edward R. Sherwood, M.D., Ph.D. Department of Anesthesiology The University of Texas Medical Branch Shriners Hospital for Children Galveston Burns Unit Galveston, Texas. Inflammation. - PowerPoint PPT Presentation
Citation preview
Inflammatory Response: Current Concepts
Edward R. Sherwood, M.D., Ph.D.Department of Anesthesiology
The University of Texas Medical Branch Shriners Hospital for Children
Galveston Burns Unit
Galveston, Texas
Inflammation• A protective response that removes sources of
injury and facilitates tissue repair• Uncontrolled or inappropriate inflammation can
cause injury• Inflammation-associated injuries during the
perioperative period and the ICU– Thrombosis (myocardial infarction, stroke)– Acute lung injury, ARDS– Metabolic disturbances (hyperglycemia)– Hemodynamic dysfunction (hypotension)– End organ dysfunction (renal, hepatic insufficiency)– Pain
Classification of Inflammation• Acute inflammation
– Occurs over hours, days or weeks– Characterized by vasodilation, fluid exudation and
neutrophil infiltration– Caused by acute trauma, surgery, acute infection
• Chronic Inflammation– Occurs over weeks, months or years– Characterized by vasodilation, fluid exudation and
mononuclear cell (lymphocyte/monocyte) infiltrates.
– Presence of concomitant repair (fibrosis)– Rheumatoid arthritis, atherosclerosis,
inflammatory bowel disease
Acute Inflammation• Initiation
– Increased vascular caliber and flow– Increased vascular permeability
• fluid exudation and edema formation
– Leukocyte infiltration (mainly neutrophils)
• Amplification– mediated by soluble and cellular factors
• Resolution – mediated by removal of source, anti-
inflammatory cytokines, cholinergic nervous system and apoptosis
Initiation of Acute Inflammation• Increased Vascular Diameter and Flow
– Arteriolar dilation and opening of new capillary beds
– Functional importance• Delivers soluble mediators and leukocytes to site of
injury• Promotes transvascular fluid flux
– Clinical signs• Erythema and warmth
– Pathology• Systemic vasodilation, low systemic vascular
resistance, hypotension
Mediators of Increased Vascular Diameter and Flow
Nitric Oxide (NO)Vascular smooth muscle relaxation and vasodilation
NO
Endothelial stimulation
Endothelium
Microbe
Macrophage
Activation stimulus
Calcium influxand eNOS activation
Cytotoxicity
NO
eNOS
iNOS
MembranePhospholipids
ArachidonicAcid
PGG2 PGH2 PGD2
PGE2
PGF2
PGI2
Cyclooxygenase(COX-1, COX-2)
Phospholipases
Vasodilatory Prostaglandins
• Transvascular Fluid Flux– Increased hydrostatic pressure causes net outflow of
fluid from vascular compartment– Increased vascular permeability (to water, solute and
protein)• Formation of endothelial gaps • Formation of transcytoplasmic channels• Direct or leukocyte-mediated endothelial injury
– Functional importance• Delivers soluble mediators (antibodies, acute phase proteins) to
site of injury
– Clinical signs• Edema formation
– Pathology• ARDS, interstitial edema
Initiation of Acute Inflammation
Burn Shock• Edema formation
– Increased vascular permeability• Solutes• Electrolytes• Colloids
– Decreased plasma oncotic pressure (hypoproteinemia)
• Intravascular hypovolemia• Increased systemic vascular resistance• Tissue hypoperfusion, metabolic acidosis
Burn Shock: Edema Formation
From Demling R, J Burn Care Rehab 26:207, 2005
Clinical Ramifications of Transvascular Fluid Flux
Clinical Ramifications of Transvascular Fluid Flux
Mediators of Increased Vascular Permeability
• Histamine• Bradykinin• Substance P• Leukotrienes
MembranePhospholipids
ArachidonicAcid
5-HPETE LTA4
5- LipoxygenasePhospholipases
LTC4
LTD4
LTE4
LTB4 chemotaxis
Increasevascular permeability
• Leukocyte (neutrophil) Infiltration– Process
• Margination• Rolling• Adhesion• Transmigration• Chemotaxis
– Functional importance• Phagocytosis, removal of bacteria and debris
– Pathology• Acute lung injury, ischemia-reperfusion injury
Initiation of Acute Inflammation
Neutrophil Adhesion and Chemotaxis
Adapted from Seely et al, Crit Care 7:291-307, 2003
Rolling 1
Adherance 2
Transmigration 3
Chemotaxis:Chemokines
Bacterial productsLTB4
4
Phagocytosis5
Apoptosis 6
E-selectinP-selectin
Lectins integrinsICAM-1
PECAM
Endothelium
Ischemia-Reperfusion Injury
Adapted from Shernan, Anesthesiology Clinics of North America 21:2003
1
2
3
4
5
6
Interactions Between Inflammation and Coagulation
Macrophage/Monocyte
Endothelial Cell
Tissue Factor
TNFIL-1
VIIIa IXa
Va
Xa
Thrombin
Fibrin clot
Activated Protein C
Macrophage/MonocyteActivation
(-)
(-)
Degradation of Va and VIIIa
Anti-ThrombinIII
Intrinsic Pathway
+
VIIaTissue FactorPathway InhibitorBinds TF-VIIaComplex
Binds Thrombin
Role of Complement in Systemic Inflammation
Adapted from Rittirsch et al, Nat Rev Immunol 8:776, 2008
• Myocardial Infarction– Inflammation is associated with increased risk of
plaque rupture and acute coronary syndromes• Koenig et al, Arthersler Thromb Vasc Biol 27:15, 2006
– Risk of post-operative MI associated with SNPs in IL-6, ICAM-1,CRP and E-selectin genes
• Podgoreanu et al, Circulation 114:I275, 2006
• Stroke– Risk of post-operative stroke in cardiac surgery
patients associated with SNPs in IL-6 and CRP genes
• Grocott et al, Stroke 36:1854, 2005
Potential Thrombotic Complications Associated with Perioperative Inflammation
Systemic Effects of Inflammation
EdemaPainErythema
Adapted from Abbas et al, Cellular and Molecular Immunology, 2001
Myocardialdepression
MetabolicDysfunction
Cachexia,Fever
Edema
The Systemic Inflammatory Response Syndrome (SIRS) and Sepsis
Sepsis and SIRS• Tachycardia • Tachypnea • Leukocytosis or
leukopenia • Fever or hypothermia
Severe Sepsis/SIRS• Hemodynamic alterations
– Hypotension, decreased SVR• Tissue Hypoperfusion or
impaired oxygen utilization– Lactic acidosis
• Organ Dysfunction– Renal failure, mental status
changes, thrombocytopenia, ARDS,coagulopathy
• Metabolic dysfunction– Hyperglycemia
Bone et al, Crit Care Med 20, 1992; Bone et al Chest 101, 1992Levy et al, Crit Care Med 31, 2003
Current Treatment of Severe SIRS/Septic Shock
• Cardiopulmonary/Organ-specific Support– Goal directed fluid resuscitation– Inotropic support– Mechanical ventilation– Treat metabolic, coagulation and end organ
dysfunction
• Remove infection/sources of inflammation– Antibiotics– Drain Abscess– Excise Necrotic/Inflamed Tissue
Potential Anti-inflammatory Treatment Approaches
• Block/remove inflammatory mediators
• Inhibit inflammatory response
• Reduce cellular injury
• Inhibit coagulation cascade
Anti-inflammatory Therapy of Sepsis:Block Mediators
Adapted from Natanson et al, Crit Care Med 1998
TNF-MAb
TNF-MAb
TNF-MAb
TNF-MAb
sTNFr
sTNFr
IL-1ra
IL-1ra
PAFra
PAFra
Anti-bradykinin
ibuprofen
0.5 0.67 1 1.5 2 Odds ratio
benefitinjury
Anti-inflammatory Therapy of Sepsis• Hemofiltration• Complement antagonism
– C1 inhibitor (blocks classical/lectin pathways)
• Anti-adhesion molecule – Selectins, ICAM-1
• Blockade of Nitric Oxide– iNOS inhibition, NO scavenging
• Phosphodiesterase inhibitors– Pentoxifylline, milrinone
• Anti-oxidants– Selenium, N-acetylcysteine, Vit. C and E
Steroids in Septic Shock
Cronin et al, Crit Care Med 1995
High dose (30 mg/kg
prednisone)Short term(1-3 days)steroids
Steroids in Septic Shock• Patients in septic shock with low adrenal reserve (corticotropin stimulation
test) showed improved survival when treated with replacement corticosteroids
• Replacement dose steroids may only have benefit in septic patients with vasopressor-refractory hypotension (CORTICUS), Z. Thomas, Ann Pharmacother 41:1456, 2007
• ‘Intravenous corticosteroids (hydrocortisone 200–300 mg/day, for seven days in three or four divided doses or by continuous infusion) are suggested in patients with septic shock whose blood pressure is poorly responsive to fluid replacement and vasopressor therapy.’ Surviving Sepsis Campaign, Crit Care Med 36:296, 2008
Annane et al, JAMA 288:862, 2002
Biology of Activated Protein C
Cytokine Production
inhibit
induce
Fibrin clot Formation
Cytokine Production Fibrin clot
Formation
Inflammation Thrombosis
Normal Sepsis
Tissue factor
Tissue factor
Proteolysis of factors Va and VIIIaProfibrinolysis
Activated protein C Protein C
Adapted from Kumar et al, Robbins Textbook of Pathology
Consumption ofProtein C
Treatment of Severe Sepsis with Activated Protein C
• Mortality due to all causes significantly improved in patients treated with activated protein C (APC)
• 1 life saved for every 16 patients treated with APC
• Decreased IL-6 and D Dimer levels in APC-treated patients
69.2%
75.3%
Bernard et al NEJM 2001
placebo
Activated protein C
Treatment of Severe Sepsis with Activated Protein C
From Vincent et al, Crit Care 10:R274, 2006
Treatment of Patients with Severe Sepsis and at Lower Risk of Mortality with
Activated Protein C
From Abraham et al, NEJM 353:1332, 2005
Single organ failure
or Apache II score
less than 25
Efficacy of Activated Protein C in Patients with Severe Sepsis and Elevated Troponin Levels
Elevated TroponinNormal Troponin
From John et al, Int Care Med 33:212, 2007
APC suggested in adult patients with septic shock, organ failure and high risk of death without contraindications. Surviving Sepsis Campaign, Crit Care Med 36:296, 2008
The Autonomic Nervous System and Inflammation
From: Czura and Tracey J Int Med 257:156, 2005; Metz and Tracey Nat Immunol 6:756, 2005Pavlov et al Crit Care Med 35:1139, 2007
Summary• Our understanding of inflammation at the cellular
and molecular levels has advanced significantly during the last 20 years
• These advances have not yet translated into widespread clinical benefit in management of acute inflammatory processes although promising results with newer approaches have been obtained in some settings (e.g. Activated Protein C for severe sepsis)